An Observational Study on the Assessment of Lung Cancer Using Liquid Biopsy for Collecting miRNA Expression Profile and DNA Methylation Biomarkers.
NCT07182214 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1340
Last updated 2025-09-19
Summary
The purpose of this study is to observe whether miRNA and DNA methylation collected through liquid biopsy can serve as a biomarker for evaluating lung cancer.
Conditions
Interventions
- OTHER
-
Collect blood sample
Collect venous blood sample from subjects prior fasting, any operation or treatment
Sponsors & Collaborators
-
Pharus Taiwan, Inc.
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-05-05
- Primary Completion
- 2026-06-30
- Completion
- 2026-12-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients
NCT07012759 ·Status: RECRUITING
-
Non Small Cell Lung Cancer Evaluation According to Pre-determined Drug-targeting Tumor Markers
NCT01141686 ·Status: COMPLETED
-
Respiratory Muscle Performance and Functional Capacity in Primary Stage IIIb and IV Lung Cancer
NCT01078883 ·Status: UNKNOWN
-
Liquid Biopsy for Detection of Driver Mutation in NSCLC
NCT02778854 ·Status: UNKNOWN
-
Detection of Circulating Tumor DNA After Stereotactic Ablative Radiotherapy in Patients With Unbiopsied Lung Tumors
NCT05921474 ·Status: UNKNOWN
-
Developing Novel Circulating Epigenetic Biomarkers for Early Detection of Lung Cancer
NCT04814407 ·Status: RECRUITING
-
Gene Mutations in Non-Small Cell Lung Cancer Cells
NCT00977509 ·Status: UNKNOWN
-
Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer
NCT01414595 ·Status: COMPLETED
-
Plasma microRNA Profiling as First Line Screening Test for Lung Cancer Detection: a Prospective Study
NCT02247453 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
NCT00450281 ·Status: COMPLETED
-
Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung Cancer
NCT05665504 ·Status: RECRUITING
-
Biomarkers for Diagnosis of Lung Cancer
NCT02050100 ·Status: COMPLETED
-
Perioperative and Postoperative Circulating Tumor Cell Monitoring in Different Stage of NSCLC
NCT07186855 ·Status: COMPLETED
-
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China
NCT03059641 ·Status: COMPLETED
-
Lung EpiCheck Biomarkers Development Study
NCT06245876 ·Status: RECRUITING
-
To Establish a Molecular Typing System for Early Diagnosis of Lung Cancer
NCT05432128 ·Status: RECRUITING
-
Identifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung Cancer
NCT00897143 ·Status: WITHDRAWN
-
DNA Analysis of Blood and Tissue from Patients with Lung Cancer
NCT00471978 ·Status: RECRUITING
-
Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants
NCT00899028 ·Status: COMPLETED
-
NSCLC Heterogeneity in Early Stage Patients and Prediction of Relapse Using a Personalized "Liquid Biopsy"
NCT03771404 ·Status: UNKNOWN ·Phase: NA
-
A Study to Examine Biomarkers From Lung and Blood Samples in Participants With Suspected Lung Cancer
NCT04951154 ·Status: COMPLETED
-
Comparision of Various Biomarkers Between Peripheral and Pulmonary Blood
NCT05587114 ·Status: RECRUITING
-
A Comprehensive Evaluation of Circulating Tumor DNA and Circulating Tumor Cells as a Predictive Marker in Lung Cancer
NCT04254497 ·Status: COMPLETED
-
Accelerating Lung Cancer Diagnosis Through Liquid Biopsy
NCT04863924 ·Status: ACTIVE_NOT_RECRUITING
-
Feasibility of Cell-Free DNA Liquid Biopsy in Screening High-Risk Patients for Lung Cancer
NCT05384769 ·Status: RECRUITING ·Phase: NA